Dynavax Technologies Corporation

Company Listings from SPi: Dynavax Technologies Corporation

You are here: Home >> SPi Company Listings >> Dynavax Technologies Corporation

 

Dynavax Technologies Corporation

Website:
http://

Search for other references to "dynavax" on SPi News

Latest Dynavax Technologies Corporation News

Dynavax Announces First Quarter 2019 Financial Results BERKELEY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vacc...... 21:05 GMT Wednesday 8th May 2019

Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease BERKELEY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developin...... 22:00 GMT Thursday 2nd May 2019

Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8 BERKELEY, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and deve...... 21:05 GMT Thursday 25th April 2019

Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019 BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and deve...... 21:05 GMT Thursday 18th April 2019

Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models BERKELEY, Calif. and PLANEGG-MARTINSRIED, Germany, April 01, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) and 4SC AG (FSE Prime Standard: VSC) today a...... 18:00 GMT Monday 1st April 2019

Dynavax Announces European Medicines Agency Accepts Marketing Authorization Application for HEPLISAV-B® for Prevention of Hepatitis B in Adults BERKELEY, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX), a fully-integrated biopharmaceutical company focused on discovering and devel...... 20:05 GMT Thursday 28th March 2019

Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019 BERKELEY, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and deve...... 20:20 GMT Wednesday 20th March 2019

Dynavax Exercises Option for $75 Million in Non-Dilutive Debt BERKELEY, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it has exercised its option to draw down million of...... 20:05 GMT Monday 18th March 2019

Dynavax to Present at 39th Annual Cowen Healthcare Conference BERKELEY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and deve...... 21:05 GMT Wednesday 6th March 2019

Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results BERKELEY, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and devel...... 21:05 GMT Tuesday 26th February 2019

Buy Dynavax Technologies Corporation
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us